Achilles Therapeutics UK Limited

W6 8PW (London)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

Sep 22 - Sep 26

Characterising the metabolic requirements of the newly-identified DC3 subset

MRC award to Queen Mary University of London

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}